Preclinical trial of the multi-targeted lenvatinib in combination with cellular immunotherapy for treatment of renal cell carcinoma.

C. Cai,Jingyuan Tang,B. Shen,L. Ding,Yunpeng Shao,Zhengsen Chen,Yinchao Ma,Haoliang Xue,Zhongqing Wei

Published 2017 in Experimental and Therapeutic Medicine

ABSTRACT

No abstract is available for this paper.

PUBLICATION RECORD

Publication year
2017
Venue
Experimental and Therapeutic Medicine
Publication date
2017-10-01
Fields of study
Medicine
Identifiers
DOI 10.3892/etm.2017.4858 PMID 28912872 PMCID PMC5585750
External record
Open on Semantic Scholar
Source metadata
Semantic Scholar, PubMed

CITATION MAP

EXTRACTION MAP

CLAIMS

No claims are published for this paper.

CONCEPTS

No concepts are published for this paper.

REFERENCES

Comprehensive Analysis of the Incidence and Survival Patterns of Lung Cancer by Histologies, Including Rare Subtypes, in the Era of Molecular Medicine and Targeted Therapy
2015cited by this paper
Comparative analysis of the effectiveness of abiraterone before and after docetaxel in patients with metastatic castration-resistant prostate cancer.
2015cited by this paper
The Histone Deacetylase Inhibitor Trichostatin A Sensitizes Human Renal Carcinoma Cells to TRAIL-Induced Apoptosis through Down-Regulation of c-FLIPL
2015cited by this paper
Lenvatinib Extends Survival in Metastatic Renal-Cell Carcinoma.
2015cited by this paper
Immunotherapy Targeting Folate Receptor Induces Cell Death Associated with Autophagy in Ovarian Cancer
2014cited by this paper
'Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF)' by Yamamoto, N., Suyama, H., Yamamoto, N. and Ushijima, N.
2014cited by this paper
Targeted therapies and complete responses in first line treatment of metastatic renal cell carcinoma. A meta-analysis of published trials.
2014cited by this paper
A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy.
2014cited by this paper
Immunotherapy and complexity: overcoming barriers to control of advanced cancer.
2014cited by this paper
Improvements in Health-Related Quality of Life by Comprehensive Cancer Pain Therapy: A Pilot Study with Breast Cancer Outpatients under Palliative Chemotherapy
2014cited by this paper
Immunotherapy for Brain Cancer: Recent Progress and Future Promise
2014cited by this paper
Immunotherapy in lung cancer.
2014cited by this paper
Immunotherapy for Lung Cancer: Has it Finally Arrived?
2014cited by this paper
Potential interactions of complementary and alternative medicine with cancer therapy in outpatients with gynecological cancer in a comprehensive cancer center
2013cited by this paper
A phase 1b clinical trial of the multi-targeted tyrosine kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC)
2013cited by this paper
Cytokine patterns in patients with cancer: a systematic review.
2013cited by this paper
A phase I study of E7080, a multitargeted tyrosine kinase inhibitor, in patients with advanced solid tumours
2012cited by this paper
A mechanistic analysis of the quantitation of α-hydroxy ketones by the bicinchoninic acid assay.
2012cited by this paper
Resistance to Cancer Treatment: The Role of Somatic Genetic Events and the Challenges for Targeted Therapies
2011cited by this paper
Phase I Dose-Escalation Study and Biomarker Analysis of E7080 in Patients with Advanced Solid Tumors
2011cited by this paper
Combination of radiotherapy and targeted therapies in the treatment of locally advanced non-small cell lung cancer
2011cited by this paper
A phase 1 study of everolimus and sorafenib for metastatic clear cell renal cell carcinoma
2011cited by this paper
Targeted therapies for the treatment of metastatic renal cell carcinoma: clinical evidence.
2011cited by this paper
Targeted therapies in the treatment of gastric cancer
2011cited by this paper
Targeted therapies: Congratulations, you are still in the running towards becoming ovarian-next-top treatment
2011cited by this paper
Castration-Resistant Prostate Cancer: Targeted Therapies and Individualized Treatment
2011cited by this paper
Antineoplastic therapy use in patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center
2010cited by this paper
Phase II trial of bevacizumab and everolimus in patients with advanced renal cell carcinoma.
2010cited by this paper
Immunotherapy. Significant overall survival advantage for RCC patients treated with autologous tumor lysate vaccine.
2010cited by this paper
Risk factors: Oncotype DX® assay predicts local recurrence in breast cancer
2010cited by this paper
Inhibiting the inhibitors: evaluating agents targeting cancer immunosuppression
2010cited by this paper
Treatment of advanced pancreatic cancer: from gemcitabine single agent to combinations and targeted therapy.
2009cited by this paper
Diagnostic and prognostic molecular markers for renal cell carcinoma: a critical appraisal of the current state of research and clinical applicability.
2009cited by this paper
Resistance to targeted therapy in renal-cell carcinoma.
2009cited by this paper
Renal-cell carcinoma--molecular pathways and therapies.
2007cited by this paper
Targeted therapies in the treatment of gastric cancer
2006cited by this paper
In vitro assessment of cytotoxic agent combinations for hormone-refractory prostate cancer treatment
2005cited by this paper
[New concepts of perioperative comprehensive therapy for non-small cell lung cancer].
2005cited by this paper
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
2001cited by this paper
Regulation of tumor growth by IFN-gamma in cancer immunotherapy.
2001cited by this paper
Combinations of three chemotherapeutic agents and two chemotherapeutic agents plus a targeted biologic agent in the treatment of advanced non small-cell lung cancer.
2000cited by this paper

CITED BY